News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
29-May-2012 - In many biological and pathological processes, glycosidase enzymes attack glycosidic bonds in carbohydrates, glycoproteins, and glycolipids. The ability to modify or block these processes by specific glycosidase inhibitors forms the basis for their potential use in the treatment of viral ...
19-Apr-2012 - OctoPlus N.V. announces that the Supervisory Board of the Company will nominate Catherine Moukheibir to be appointed as member of the Supervisory Board at the next General Meeting of Shareholders. This appointment will be for a period of four years. Catherine Moukheibir MA, MBA, age 52, was CFO ...
10-Apr-2012 - Amsterdam Molecular Therapeutics (AMT) Holding N.V. in liquidation (in liquidatie), announced that following the approval of the corporate restructuring and financing transaction by the Extraordinary General Meeting ("EGM") of shareholders that was held on 30 March 2012, completion of the ...
Synthon intends to defend vigorously
10-Apr-2012 - Synthon has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for glatiramer acetate, 20 mg/ml solution for injection in pre-filled syringes. The reference listed drug for glatiramer acetate is Copaxone, indicated for reduction of the frequency of ...
Biomass transferred into valuable chemicals
06-Feb-2012 - Funded by the Knowledge Based Bio Economy program of the EU, the 13 M€ BioConSepT project starts in February 2012. The project wants to convince and inspire stakeholders of the Bio-based Economy by demonstrating the complete feasibility of an integrated chain approach, which is regarded as the ...
03-Feb-2012 - OctoPlus N.V. announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S. The undisclosed contract value will make a material contribution to OctoPlus' 2012 revenues. Further details on the compound and activities are not disclosed.
03-Jan-2012 - Amsterdam Molecular Therapeutics announced that the Company has raised € 2.5 million in new equity by means of a private placement to three of its existing shareholders: Forbion Capital Partners, Gilde Healthcare Partners and Advent Venture Partners. Under the terms of the transaction, AMT has ...
12-Dec-2011 - Elsevier announced the acquisition of the business assets of Ariadne Genomics. Ariadne will be integrated with Elsevier’s Corporate Markets division.“Ariadne Genomics’ pathway analysis tools and semantic technologies integrate research findings from across multiple content sources providing a ...
05-Dec-2011 - ModiQuest Research has successfully generated novel antibody therapeutic leads and diagnostics for rheumatoid arthritis (RA). Using its extensive antibody generation technology platform, which includes phage display and high throughput mouse hybridoma generation, the company identified specific ...
16-Nov-2011 - Mucosis B.V. announced that it has appointed professors Jiri Mestecky, M.D., Ph.D.; Willem van Eden, M.D., Ph.D.; and Peter J. Openshaw, M.B., B.S., Ph.D., F.Med.Sci., to its newly formed Scientific Advisory Board.Dr. Mestecky is with the Department of Microbiology and Medicine at the University ...
© 1997-2024 LUMITOS AG, All rights reserved